Dalane W. Kitzman

Active 1988–2025

Also published as
Dalane W Kitzman
263
Papers
52,355
Citations
120
h-index
253
i10-index

Citations

Citations per year for Dalane W. Kitzman1988: 3 citations1989: 1 citations1990: 3 citations1991: 7 citations1992: 3 citations1993: 6 citations1994: 4 citations1995: 11 citations1996: 17 citations1997: 21 citations1998: 15 citations1999: 14 citations2000: 38 citations2001: 66 citations2002: 117 citations2003: 134 citations2004: 202 citations2005: 182 citations2006: 205 citations2007: 168 citations2008: 207 citations2009: 197 citations2010: 252 citations2011: 286 citations2012: 297 citations2013: 271 citations2014: 378 citations2015: 414 citations2016: 436 citations2017: 465 citations2018: 426 citations2019: 1,441 citations2020: 1,516 citations2021: 1,688 citations2022: 1,519 citations2023: 1,173 citations2024: 2,578 citations2025: 1,903 citations2026: 57 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,311 citing papers, 25.9% of this breakdownUnited Kingdom: 1,467 citing papers, 7.2% of this breakdownItaly: 1,204 citing papers, 5.9% of this breakdownChina: 1,154 citing papers, 5.6% of this breakdownGermany: 941 citing papers, 4.6% of this breakdownCanada: 925 citing papers, 4.5% of this breakdownNetherlands: 770 citing papers, 3.8% of this breakdownAustralia: 662 citing papers, 3.2% of this breakdownFrance: 592 citing papers, 2.9% of this breakdownSpain: 571 citing papers, 2.8% of this breakdownJapan: 550 citing papers, 2.7% of this breakdownSweden: 438 citing papers, 2.1% of this breakdown
0%25.9%Other 28.8%

Fields

  • Medicine82.4%
  • Biochemistry, Genetics and Molecular Biology10.9%
  • Immunology and Microbiology1.1%
  • Engineering1%
  • Agricultural and Biological Sciences0.9%
  • Health Professions0.8%
  • Other2.9%

Topics

  • Cardiovascular Function and Risk Factors10.8%
  • Heart Failure Treatment and Management7.5%
  • Cardiovascular and exercise physiology3.8%
  • Diabetes Treatment and Management3.1%
  • Cardiac Valve Diseases and Treatments2.4%
  • Cardiac Imaging and Diagnostics2.4%
  • Other70%

Coauthors

All papers

Open in search
  1. Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark C. Petrie - New England Journal of Medicine 2023 cited by 1,436

  2. Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dennis Wolf, Sanjiv J. Shah - New England Journal of Medicine 2024 cited by 632

  3. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets

    Authors: , , , , , - Cardiovascular Research 2022 cited by 413

  4. Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dennis Wolf, Mikhail Kosiborod - The Lancet 2024 cited by 323

  5. Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , - JAMA 2016 cited by 879

  6. The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2021 cited by 604

  7. Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2023 cited by 188

  8. A mechanism by which gut microbiota elevates permeability and inflammation in obese/diabetic mice and human gut

    Authors: , , , , , , , , , , - Gut 2023 cited by 261

  9. Gut microbiome and aging: Physiological and mechanistic insights

    Authors: , , , , , , , , , - Nutrition and Healthy Aging 2017 cited by 655

  10. Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet 2024 cited by 264

  11. Physical Rehabilitation for Older Patients Hospitalized for Heart Failure

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2021 cited by 547

  12. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Margaret B. Fraenkel, Martin Gallagher, Timothy M. E. Davis, Shamasunder Acharya, Duncan Cooke, Michael Suranyi, Simon D. Roger, Nigel D. Toussaint, Carol A. Pollock, Doris Chan, Stephen Stranks, Richard J. MacIsaac, Zoltán Endre, Alice Schmidt, Rudolf Prager, Gert Mayer, Xavier Warling, Michel Jadoul, Jean Hougardy, Chris Vercammen, Bruno Van Vlem, Pieter Gillard, Adriana Costa e Forti, João Borges, Luis Santos Canani, Freddy G. Eliaschewitz, Silmara Leite, Fadlo Fraige Filho, Raphael Paschoalin, José A. Moura-Neto, Luciane Mônica Deboni, Irene de Lourdes Noronha, Cíntia Cercato, Carlos Alberto Prompt, Maria Teresa Zanella, Nelson Rassi, Domingos O. d’Avila, Rosângela Milagres, João Soares Felício, Roberto Pecoits‐Filho, Miguel C. Riella, João Eduardo Nunes Salles, Elizete Keitel, Sérgio Antônio Draibe, Celso Amodeo, J. T. Youmbissi, Louise Roy, Serge Cournoyer, Shivinder Jolly, Vincent Pichette, Gihad Nesrallah, Harpreet S. Bajaj, Hasnain Khandwala, Ronnie Aronson, Richard Goluch, Paul Kwong Hang Tam, Christian Rabbat, Sheldon W. Tobe, G. HOWARD BAILEY, S. P. Chow, A Castillo, Alfredo Danin Vargas, Fernando González, Rodrigo Muñoz, Vicente Gutiérrez, Gonzalo Godoy, Hongwen Zhao, Zhangsuo Liu, Ming‐Hui Zhao, Xiaohui Guo and 610 more - The Lancet 2019 cited by 612

  13. Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , - Circulation 2016 cited by 980

  14. Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure

    Authors: , , , , , , , , , , , , , , , , , - JAMA 2009 cited by 2,167

  15. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2016 cited by 1,239

  16. Research Priorities for Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , - Circulation 2020 cited by 417

  17. Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology

    Authors: , , , , , , , , , , , - Circulation 2019 cited by 558

  18. Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome

    Authors: , , , , , , , , , - Scientific Reports 2018 cited by 368

  19. Frailty Is Intertwined With Heart Failure

    Authors: , , - JACC Heart Failure 2019 cited by 325

  20. Lipoteichoic acid from the cell wall of a heat killed Lactobacillus paracasei D3-5 ameliorates aging-related leaky gut, inflammation and improves physical and cognitive functions: from C. elegans to mice

    Authors: , , , , , , , , , , , - GeroScience 2019 cited by 212

  21. Clinical Recommendations for Cardiopulmonary Exercise Testing Data Assessment in Specific Patient Populations

    Authors: , , , , , , , , , , , - Circulation 2012 cited by 814

  22. Supervised Exercise Training for Chronic Heart Failure With Preserved Ejection Fraction: A Scientific Statement From the American Heart Association and American College of Cardiology

    Authors: , , , , , , , , , , , , , , - Circulation 2023 cited by 121

  23. Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial

    Authors: , , , , , , , , , , , , , , - Circulation 2023 cited by 92

  24. Metformin Reduces Aging-Related Leaky Gut and Improves Cognitive Function by Beneficially Modulating Gut Microbiome/Goblet Cell/Mucin Axis

    Authors: , , , , , , , , , , , , - The Journals of Gerontology Series A 2020 cited by 144